Searched for
UNLOXCYT APPROVAL
New launches and R&D pipeline bolster Sun Pharma's long-term growth outlookSun Pharma reported robust global specialty growth and resilient domestic sales in Q3, despite US generics headwinds. Recent product launch...10 Nov, 2025, 06.25 AM IST- Sun Pharma Q2 Preview: PAT may rise 2% YoY; Leqselvi spending to weigh on marginsSun Pharma is expected to report modest Q2 FY26 earnings growth, with PAT likely up 2% YoY and revenue rising 7%. Analysts cite Leqselvi la...04 Nov, 2025, 01.46 PM IST
- Sun Pharma lines up $100 mn to commercialise niche products this fiscalSun Pharmaceutical Industries plans a USD 100 million investment to commercialize innovative products this fiscal year, focusing on its spe...02 Jun, 2025, 12.18 AM IST
- I-Sec upgrades Sun Pharma to Buy, target price Rs 1,895ICICI Securities has upgraded Sun Pharmaceutical Industries to 'Buy' with a revised target price of Rs 1895. Sun Pharma, a leading company ...13 Mar, 2025, 08.51 AM IST
- Stocks to buy today: IndusInd Bank gets a downgrade; Motilal Oswal sees over 20% upside in Sun PharmaNuvama has downgraded IndusInd Bank to "Reduce" citing concerns over internal derivative trades and management changes, while Antique remai...11 Mar, 2025, 10.09 AM IST
- Sun Pharma shares in focus as co to acquire Checkpoint Therapeutics for $355 millionSun Pharmaceutical announced the acquisition of Nasdaq-listed Checkpoint Therapeutics, an immunotherapy and oncology company. The deal invo...10 Mar, 2025, 09.25 AM IST
- Sun Pharmaceuticals to acquire Checkpoint Therapeutics for $355 mnSun Pharmaceuticals will acquire Checkpoint Therapeutics for $355 million, bringing the FDA-approved anti-PD-L1 treatment for advanced cuta...10 Mar, 2025, 07.59 AM IST
Load More
